Jennifer A Iddings1, Anastasia Zarkou1, Edelle C Field-Fote1,2,3. 1. Spinal Cord Injury Research Laboratory, Crawford Research Institute, Shepherd Center. 2. Division of Physical Therapy, School of Medicine, Emory University. 3. Program in Applied Physiology, School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.
Abstract
PURPOSE OF REVIEW: This review will focus on the use of clinically accessible neuromodulatory approaches for functional restoration in persons with spinal cord injury (SCI). RECENT FINDINGS: Functional restoration is a primary rehabilitation priority for individuals with SCI. High-tech neuromodulatory modalities have been used in laboratory settings to improve hand and walking function as well as to reduce spasticity and pain in persons with SCI. However, the cost, limited accessibility, and required expertise are prohibitive for clinical applicability of these high-tech modalities. Recent literature indicates that noninvasive and clinically accessible approaches targeting supraspinal, spinal, and peripheral neural structures can modulate neural excitability. Although a limited number of studies have examined the use of these approaches for functional restoration and amelioration of secondary complications in SCI, early evidence investigating their efficacy when combined with training is encouraging. SUMMARY: Larger sample studies addressing both biomarker identification and dosing are crucial next steps in the field of neurorehabilitation research before novel noninvasive stimulation approaches can be incorporated into standard clinical practice.
PURPOSE OF REVIEW: This review will focus on the use of clinically accessible neuromodulatory approaches for functional restoration in persons with spinal cord injury (SCI). RECENT FINDINGS: Functional restoration is a primary rehabilitation priority for individuals with SCI. High-tech neuromodulatory modalities have been used in laboratory settings to improve hand and walking function as well as to reduce spasticity and pain in persons with SCI. However, the cost, limited accessibility, and required expertise are prohibitive for clinical applicability of these high-tech modalities. Recent literature indicates that noninvasive and clinically accessible approaches targeting supraspinal, spinal, and peripheral neural structures can modulate neural excitability. Although a limited number of studies have examined the use of these approaches for functional restoration and amelioration of secondary complications in SCI, early evidence investigating their efficacy when combined with training is encouraging. SUMMARY: Larger sample studies addressing both biomarker identification and dosing are crucial next steps in the field of neurorehabilitation research before novel noninvasive stimulation approaches can be incorporated into standard clinical practice.
Authors: M A Nitsche; S Doemkes; T Karaköse; A Antal; D Liebetanz; N Lang; F Tergau; W Paulus Journal: J Neurophysiol Date: 2007-01-24 Impact factor: 2.714
Authors: Abel Torres-Espín; Juan Forero; Keith K Fenrich; Ana M Lucas-Osma; Aleksandra Krajacic; Emma Schmidt; Romana Vavrek; Pamela Raposo; David J Bennett; Phillip G Popovich; Karim Fouad Journal: Brain Date: 2018-07-01 Impact factor: 13.501
Authors: Paul J Wrigley; Sylvia M Gustin; Leigh N McIndoe; Rosemary J Chakiath; Luke A Henderson; Philip J Siddall Journal: Pain Date: 2013-07-04 Impact factor: 6.961
Authors: Edelle C Field-Fote; Catherine L Furbish; Natalie E Tripp; Jeanne M Zanca; Trevor Dyson-Hudson; Steven Kirshblum; Allen W Heinemann; David Chen; Elizabeth Roy Felix; Lynn Worobey; Mary Schmidt-Read; Ralph J Marino; Matthew J Hayat Journal: Arch Phys Med Rehabil Date: 2021-05-17 Impact factor: 3.966